Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
For example, older people (because absorption declines with age) and those with gut-related conditions such as celiac disease and Crohns disease may struggle to absorb enough vitamin B12 to stave off symptoms of a deficiency, says Foxx
Other potential serious side effects include changes in vision and kidney problems
Key Market Growth Drivers Rapid rise in global type 2 diabetes prevalence Strong clinical outcomes in glycemic control and weight reduction Expanding use in obesity and cardiometabolic risk management Innovation in weekly injectables and oral GLP-1 formulations Growing patient preference for dual-benefit metabolic therapies Key Players in the GLP-1 Diabetes Treatment Drugs Market Eli Lilly and Company Sanofi Novo Nordisk Beijing Hanmi Pharmaceutical Co., Ltd
US$ 29.55
US$ 25.39
US$ 24.65
US$ 24.23
US$ 23.22
US$ 20.93
US$ 26.91
